427 related articles for article (PubMed ID: 17911091)
1. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
[TBL] [Abstract][Full Text] [Related]
2. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J
J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
[TBL] [Abstract][Full Text] [Related]
4. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD; MacLeod R; Rigby E; Clark AG
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[TBL] [Abstract][Full Text] [Related]
5. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.
Donia AF; Gazareen SH; Ahmed HA; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
Nephrol Dial Transplant; 2003 Oct; 18(10):2054-8. PubMed ID: 13679480
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.
Wang S; Li X; Qu L; Wang R; Chen Y; Li Q; He X; Zhang X; Wang H; Wu J; Xu Y; Chen J
Lupus; 2012 Aug; 21(9):1025-35. PubMed ID: 22570338
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
Gulati S; Prasad N; Sharma RK; Kumar A; Gupta A; Baburaj VP
Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
[TBL] [Abstract][Full Text] [Related]
10. Effective treatment administration of cyclophosphamide in membranous nephropathy.
Dede F; Ayili D; Sahiner S
J Nephrol; 2008; 21(4):560-5. PubMed ID: 18651546
[TBL] [Abstract][Full Text] [Related]
11. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
[TBL] [Abstract][Full Text] [Related]
12. Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids.
He L; Peng Y; Liu H; Liu Y; Yuan S; Liu F; Yang D; Liu H; Chen X; Shao J; Fu M
J Nephrol; 2013; 26(3):564-71. PubMed ID: 22956434
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus as rescue therapy for adult-onset refractory minimal change nephrotic syndrome with reversible acute renal failure.
Li X; Xu N; Li H; Han F; Wang R; He Q; He X; Chen J
Nephrol Dial Transplant; 2013 Sep; 28(9):2306-12. PubMed ID: 23787554
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial.
Ren H; Shen P; Li X; Pan X; Zhang W; Chen N
Am J Nephrol; 2013; 37(1):84-90. PubMed ID: 23343906
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
Kashtan C; Melvin T; Kim Y
Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
[TBL] [Abstract][Full Text] [Related]
18. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
Donia AF; Amer GM; Ahmed HA; Gazareen SH; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
[TBL] [Abstract][Full Text] [Related]
20. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
Duncan N; Dhaygude A; Owen J; Cairns TD; Griffith M; McLean AG; Palmer A; Taube D
Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
